Our first edition of 2022 focuses on Healthcare and Life Sciences. It is a sector that will once again have the spotlight on it this year as we continue to tackle COVID-19 and its subsequent variants. While the pandemic continues to challenge the sector, governments across the region forge ahead with their plans to expand and upgrade healthcare systems and develop robust world-class healthcare infrastructure.
For the region, healthcare is a vital pillar in diversifying its economies, both locally and as medical tourism hubs. To underpin this, healthcare authorities across the region continue to implement frameworks and regulations that provide structure and accountability.
In this edition, you have unique access to great insights and expert commentary on a number of pertinent healthcare regulatory developments. You will find a topical mix of articles; for example, our lawyers discuss vaccines and returning to work during the pandemic. They take you through several other areas, including stem cell research in Bahrain, clinical research laws in Egypt, and Saudi medical device and pharmaceutical laws.Take a read of the edition
On Wednesday the 2nd of December 2020 the Ministry of Commerce (“MOC”) announced the issuance of a ministerial resolution (no. 348) and two circulars to suspend some of the provisions of the Companies Law , pursuant to an earlier a royal decree .
This royal decree was among several initiatives designed to ease economic difficulties facing companies, as a result of the COVID-19 pandemic, by giving authority to the Minister of Commerce to suspend Companies Law provisions that had become difficult to comply with.
The suspended provisions affect limited liability companies and closed joint stock companies, as they are the most regulated entity types and those most adopted by both local and foreign investors.
The provisions above will last until 31 December 2020.
However, the director(s) or the board of directors of the limited liability company must comply with the following:
Al Tamimi & Company’s specialist Corporate Structuring and Corporate Commercial teams are experienced in providing bespoke, creative solutions and strategies for our clients on all aspects related to corporate law and in particular, advising on business structures available to foreign companies in the Kingdom of Saudi Arabia.
 Royal Decree (M/3) Dated 28/01/1437 (corresponding to 12/11/2015G)
 Royal Decree no. 15016 dated 2 November 2020